Safety, Immunogenicity and Pharmacokinetics of SYN004 in Patients With Solid Tumors

Clinical trial NCT02391727 · COMPLETED

Trial details

NCT number: NCT02391727
Sponsor: Synermore Biologics Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Colon Cancer, Breast Cancer, Cancer of the Head and Neck

Start date: 2015-05-01
Primary completion: 2018-10-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.